External beam radiotherapy dose response characteristics of 1127 men with prostate cancer treated in the PSA era

International Journal of Radiation Oncology Biology Physics

Volumn 48, Issue 2, 2000, Pages 507-512

  Pollack, Alan ^a,b   Smith, Lewis G ^a   Von Eschenbach, Andrew C ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Dose; Prostate specific antigen; Radiotherapy

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

AGED; ANALYSIS OF VARIANCE; ARTICLE; BLOOD; CANCER STAGING; FOLLOW UP; HUMAN; MALE; MIDDLE AGED; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; PROSTATE TUMOR; RADIATION DOSE; TREATMENT FAILURE;

AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE; TREATMENT FAILURE;

EID: 0034268588     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(00)00620-9     Document Type: Article

References (13)

1. G.E Hanks T.E Schultheiss A.L Hanlon M Hunt W.R Lee Optimization of conformal radiation treatment of prostate cancer Report of a dose escalation study Int J Radiat Oncol Biol Phys 37 1997 543 550
2. M.J Zelefsky S.A Leibel P.B Baudin G.J Kutcher Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer Int J Radiat Oncol Biol Phys 41 1998 491 500
3. A Pollack G.K Zagars External beam radiotherapy dose response of prostate cancer Int J Radiat Oncol Biol Phys 39 1997 1011 1018
4. A Pollack G.K Zagars External beam radiotherapy for stage T1/T2 prostate cancer How does it stack up? Urology 51 1998 258 264
5. R.H Liebross A Pollack S.P Lankford G.K Zagars A.C von Eschenbach F.B Geara Transrectal ultrasound for staging prostate cancer prior to radiation therapy An evaluation based on disease outcome Cancer 85 1999 1577 1585
6. R.H Leibross A Pollack S.P Lankford A.C von Eschenbach G.K Zagars Relationship of ultrasound staging and bilateral biopsy positivity to outcome in stage T1c prostate cancer treated with radiotherapy Urology 52 1998 647 652
7. A.V Roy M.E Bower J.E Hayden Sodium thymolphthalein monophosphate A new acid phosphatase substrate with greater specificity for the prostatic enzyme in serum Clin Chem 17 1971 1093 1102
8. A Pollack G.K Zagars G Starkschall C.H Childress S Kopplin A.L Boyer I.I Rosen Conventional versus conformal radiotherapy for prostate cancer Preliminary results of dosimetry and acute toxicity Int J Radiat Oncol Biol Phys 34 1996 555 564
9. Harris EK, Albert A. Survivorship analysis for clinical studies. New York: Marcel Dekker; 1991. p. 5–125.
10. Cox DR, Oakes D. Analysis of survival data. London: Chapman and Hall; 1984. p. 110–120.
11. W.H Pinover A.L Hanlon E.M Horwitz G.E Hanks Defining the appropriate dose for prostate cancer patients with PSA <10 ng/ml Int J Radiat Oncol Biol Phys 42 Suppl 1998 142
12. G.K Zagars A Pollack L.G Smith Conventional external-beam radiation therapy alone or with androgen ablation for clinical stage III (T3, NX/NO, MO) adenocarcinoma of the prostate Int J Radiat Oncol Biol Phys 44 1999 809 819
13. G.K Zagars A Pollack A.C von Eschenbach Management of unfavorable locoregional prostate carcinoma with radiation and androgen ablation Cancer 80 1997 764 775